China Summit Capital Joins $10M Series B Round In Impact Therapeutics

This Data Is Locked!

This area is available only to Subscribers.

Chinese drug development start-up Impact Therapeutics has raised around US$10 million series B financing from new investors China Summit Capital, Guangzhou Yuexiu Industrial Investment Fund,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?